OXT and pulmonary arterial hypertension: [1-4] However, the low rate of correct use of AMTSL practice, use of ergometrine and suboptimal dosages of oxytocin are major barriers to effective PPH prevention in the country and this could slow down achievement of the MDGs of reducing the MMR by 75% by 2015.